These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 28321001

  • 1. Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring　- The NOCTURNE Study.
    Kario K, Tomitani N, Kanegae H, Ishii H, Uchiyama K, Yamagiwa K, Shiraiwa T, Katsuya T, Yoshida T, Kanda K, Hasegawa S, Hoshide S.
    Circ J; 2017 Jun 23; 81(7):948-957. PubMed ID: 28321001
    [Abstract] [Full Text] [Related]

  • 2. Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis.
    Agarwal R, Weir MR.
    J Hypertens; 2013 Aug 23; 31(8):1692-701. PubMed ID: 23697963
    [Abstract] [Full Text] [Related]

  • 3. The effects of increasing calcium channel blocker dose vs. adding a diuretic to treatment regimens for patients with uncontrolled hypertension.
    Tani S, Asayama K, Oiwa K, Harasawa S, Okubo K, Takahashi A, Tanabe A, Ohkubo T, Hirayama A, Kushiro T.
    Hypertens Res; 2017 Oct 05; 40(10):892-898. PubMed ID: 28446804
    [Abstract] [Full Text] [Related]

  • 4. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G, I-ADD Study Investigators.
    Clin Ther; 2012 Aug 05; 34(8):1720-34.e3. PubMed ID: 22853847
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
    Imaizumi S, Shiga Y, Ogawa M, Sako H, Nagata Y, Matsunaga A, Shirotani T, Hoshino F, Yahiro E, Uehara Y, Morito N, Tanigawa H, Shimono D, Fukushima M, Sugihara H, Norimatsu K, Kusumoto T, Saku K, Miura SI, ACADEMIE Study Investigators.
    Heart Vessels; 2019 Apr 05; 34(4):698-710. PubMed ID: 30406819
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A, Tamura K, Kanaoka T, Ohsawa M, Haku S, Azushima K, Dejima T, Wakui H, Yanagi M, Okano Y, Fujikawa T, Toya Y, Mizushima S, Tochikubo O, Umemura S.
    Clin Exp Hypertens; 2012 Apr 05; 34(4):249-57. PubMed ID: 22571446
    [Abstract] [Full Text] [Related]

  • 8. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G, I-COMBINE Study Investigators.
    Clin Ther; 2012 Aug 05; 34(8):1705-19. PubMed ID: 22853848
    [Abstract] [Full Text] [Related]

  • 9. Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker on Diastolic Function in Hypertensive Patients.
    Toh N, Ishii K, Kihara H, Iwakura K, Watanabe H, Yoshikawa J, Ito H, Effect of ARB/Diuretics on Diastolic Function in Patients with Hypertension 2 (EDEN2) trial investigators.
    Circ J; 2016 Aug 05; 80(2):426-34. PubMed ID: 26725762
    [Abstract] [Full Text] [Related]

  • 10. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
    Stergiou GS, Makris T, Papavasiliou M, Efstathiou S, Manolis A.
    J Hypertens; 2005 Apr 05; 23(4):883-9. PubMed ID: 15775795
    [Abstract] [Full Text] [Related]

  • 11. Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine.
    Okamura K, Shirai K, Totake N, Okuda T, Urata H.
    Clin Exp Hypertens; 2018 Apr 05; 40(2):99-106. PubMed ID: 28692311
    [Abstract] [Full Text] [Related]

  • 12. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R, Michailidis P.
    Clin Ther; 2011 Sep 05; 33(9):1190-203. PubMed ID: 21885126
    [Abstract] [Full Text] [Related]

  • 13. Effect of single-pill irbesartan/amlodipine combination-based therapy on clinic and home blood pressure profiles in hypertension with chronic kidney diseases.
    Kobayashi R, Tamura K, Wakui H, Ohsawa M, Azushima K, Haku S, Uneda K, Ohki K, Haruhara K, Kinguchi S, Umemura S.
    Clin Exp Hypertens; 2016 Sep 05; 38(8):744-750. PubMed ID: 27936999
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of the combination of amlodipine and candesartan in hypertensive patients with coronary artery disease: a subanalysis of the HIJ-CREATE study.
    Koyanagi R, Hagiwara N, Yamaguchi J, Kawada-Watanabe E, Haruta S, Takagi A, Ogawa H, HIJ-CREATE Investigators.
    J Cardiol; 2013 Oct 05; 62(4):217-23. PubMed ID: 23778009
    [Abstract] [Full Text] [Related]

  • 15. Choice of Antihypertensive Combination Therapy Based on Daily Salt Intake.
    Toyoda S, Inami S, Kato T, Tsukada K, Nakamoto A, Kikegawa Y, Suzuki A, Anraku Y, Node K, Inoue T.
    Am J Med Sci; 2015 Sep 05; 350(3):160-6. PubMed ID: 26196407
    [Abstract] [Full Text] [Related]

  • 16. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K.
    Hypertens Res; 2009 Jul 05; 32(7):575-80. PubMed ID: 19444280
    [Abstract] [Full Text] [Related]

  • 17. On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone.
    Konoshita T, Kaeriyama S, Urabe M, Nakaya T, Yamada M, Ichikawa M, Yamamoto K, Sato S, Imagawa M, Fujii M, Makino Y, Zenimaru Y, Wakahara S, Suzuki J, Ishizuka T, Nakamura H, Genomic Disease Outcome Consortium (G-DOC) Study Investigators.
    Biosci Rep; 2016 Oct 05; 36(5):. PubMed ID: 27515419
    [Abstract] [Full Text] [Related]

  • 18. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study.
    Matsui Y, O'Rourke MF, Hoshide S, Ishikawa J, Shimada K, Kario K.
    Hypertension; 2012 Jun 05; 59(6):1132-8. PubMed ID: 22547439
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of arterial stiffness in morning hypertension under high-dose valsartan compared to valsartan plus low-dose diuretic.
    Takami T.
    Hypertens Res; 2009 Dec 05; 32(12):1086-90. PubMed ID: 19779491
    [Abstract] [Full Text] [Related]

  • 20. Differential blood pressure reductions by angiotensin receptor blocker plus calcium channel blocker or diuretic in elderly hypertension with or without obesity.
    Kato J, Yokota N, Tamaki N, Kariya S, Kita T, Ayabe T, Eto T, Kitamura K.
    J Am Soc Hypertens; 2012 Dec 05; 6(6):393-8. PubMed ID: 23102995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.